Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.57 - $0.99 $47,458 - $82,428
-83,261 Reduced 11.56%
636,825 $528,000
Q1 2023

May 15, 2023

BUY
$0.51 - $0.78 $46,037 - $70,410
90,270 Added 14.33%
720,086 $429,000
Q4 2022

Feb 14, 2023

SELL
$0.47 - $17.22 $202,838 - $7.43 Million
-431,571 Reduced 40.66%
629,816 $346,000
Q3 2022

Nov 14, 2022

SELL
$0.74 - $15.01 $729,640 - $14.8 Million
-986,001 Reduced 48.16%
1,061,387 $743,000
Q2 2022

Aug 15, 2022

SELL
$0.71 - $2.43 $1.44 Million - $4.94 Million
-2,033,176 Reduced 49.83%
2,047,388 $2.02 Million
Q1 2022

May 16, 2022

BUY
$2.31 - $5.13 $4.79 Million - $10.6 Million
2,075,401 Added 103.5%
4,080,564 $9.71 Million
Q4 2021

Feb 14, 2022

BUY
$4.45 - $8.09 $8.58 Million - $15.6 Million
1,927,376 Added 2477.76%
2,005,163 $9.55 Million
Q3 2021

Nov 15, 2021

BUY
$6.94 - $8.85 $539,841 - $688,414
77,787 New
77,787 $609,000
Q2 2021

Aug 16, 2021

SELL
$7.45 - $16.27 $5.9 Million - $12.9 Million
-791,320 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.78 - $12.8 $6.43 Million - $9.37 Million
732,084 Added 1235.88%
791,320 $8.96 Million
Q4 2020

Feb 16, 2021

SELL
$1.08 - $8.2 $284,850 - $2.16 Million
-263,750 Reduced 81.66%
59,236 $485,000
Q3 2020

Nov 16, 2020

BUY
$0.95 - $1.42 $274,882 - $410,877
289,350 Added 860.24%
322,986 $378,000
Q2 2020

Aug 14, 2020

BUY
$0.63 - $1.7 $7,542 - $20,352
11,972 Added 55.26%
33,636 $41,000
Q1 2020

May 14, 2020

BUY
$0.67 - $1.85 $14,514 - $40,078
21,664 New
21,664 $15,000
Q2 2019

Aug 14, 2019

SELL
$1.36 - $2.35 $146,540 - $253,212
-107,750 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$0.78 - $2.01 $54,465 - $140,352
-69,827 Reduced 39.32%
107,750 $214,000
Q4 2018

Feb 14, 2019

SELL
$0.62 - $2.25 $39,242 - $142,411
-63,294 Reduced 26.28%
177,577 $122,000
Q3 2018

Nov 14, 2018

SELL
$1.38 - $1.94 $98,599 - $138,611
-71,449 Reduced 22.88%
240,871 $429,000
Q2 2018

Aug 14, 2018

BUY
$1.73 - $3.35 $540,313 - $1.05 Million
312,320 New
312,320 $540,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.